BJS Academy>Cutting edge blog>Comment on: Role of ...
Comment on: Role of Lugol solution before total thyroidectomy for Graves’ disease: randomized clinical trial
Wei-Zhen Tang, MD1, Zhi-jian Zhou, MD, Tai-Hang Liu, PhD1
1. Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China
Correspondence to: Wei-Zhen Tang (2021220107@stu.cqmu.edu.cn) and Tai-Hang Liu (liuth@cqmu.edu.cn)
Chongqing Medical University
No.1 Yixueyuan Rd, Box 197
Chongqing 400016
China
DOI: https://doi.org/10.58974/bjss/azbc059
Related articles
Author response: Role of Lugol solution before total thyroidectomy for Graves’ disease: randomized clinical trial
Maurizio Iacobone, Francesca Torresan, Donatella Schiavone
Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
DOI: https://doi.org/10.58974/bjss/azbc060
Dear Editor
We thank Wei-Zhen Tang et al. for their interest in our paper on the role of preoperative Lugol’s Solution (LS) in Graves’ disease1. They claim the absence in the paper of details about pre-, intra- and postoperative treatments may potentially impact on the interpretation of the results. Considering only a selection of data may be presented and that further details are available on request, we would underline that most of the clinical data are presented in the paper.